Crescent Grove Advisors’s Eaton ETN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$608K Sell
1,700
-512
-23% -$182K 0.06% 166
2025
Q4
$704K Sell
2,212
-223
-9% -$79K 0.07% 156
2025
Q3
$911K Buy
2,435
+107
+5% +$38.9K 0.09% 124
2025
Q2
$831K Buy
2,328
+472
+25% +$145K 0.08% 125
2025
Q1
$504K Buy
1,856
+416
+29% +$130K 0.05% 157
2024
Q4
$478K Sell
1,440
-2
-0.1% -$702 0.05% 164
2024
Q3
$478K Buy
1,442
+121
+9% +$37K 0.05% 169
2024
Q2
$414K Sell
1,321
-3,071
-70% -$991K 0.05% 180
2024
Q1
$1.37M Hold
4,392
0.14% 95
2023
Q4
$1.06M Sell
4,392
-75
-2% -$16.6K 0.12% 111
2023
Q3
$953K Buy
4,467
+1
+0% +$216 0.12% 117
2023
Q2
$898K Buy
4,466
+1
+0% +$176 0.1% 118
2023
Q1
$765K Buy
4,465
+1
+0% +$166 0.09% 130
2022
Q4
$701K Sell
4,464
-236
-5% -$36.2K 0.07% 145
2022
Q3
$627K Buy
4,700
+1
+0% +$140 0.07% 137
2022
Q2
$592K Buy
4,699
+2
+0% +$280 0.06% 147
2022
Q1
$713K Buy
4,697
+74
+2% +$11.6K 0.07% 146
2021
Q4
$799K Buy
+4,623
New +$766K 0.08% 130

Other funds holding ETN

Crescent Grove Advisors's ETN Position: Q1 2026 in Review

Crescent Grove Advisors reduced its Eaton (ETN) stake by 23% in Q1 2026, selling an estimated $182K and leaving 1,700 shares worth $608K. The position accounts for 0.06% of the portfolio, ranked #166.

Crescent Grove Advisors first reported a position in ETN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.37M in Q1 2024. 2,508 funds tracked by Wall St. Rank hold ETN as of Q1 2026.

  • Crescent Grove Advisors held 1,700 shares of Eaton worth $608K as of Q1 2026.
  • Crescent Grove Advisors sold 512 Eaton shares in Q1 2026, an estimated $182K.
  • Eaton made up 0.06% of Crescent Grove Advisors's portfolio in Q1 2026, its #166 holding.
  • Crescent Grove Advisors first reported a position in Eaton in Q4 2021 and has held it in 18 quarters since.
  • Crescent Grove Advisors's Eaton position peaked at $1.37M in Q1 2024.
  • 2,508 funds tracked by Wall St. Rank held Eaton as of Q1 2026.

Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.